According to these observations, the 2011 Chinese National Guidelines for HIV/AIDS Diagnosis and Treatment recommended that providers weigh the benefits of NVP carefully against the risk of severe hepatoxicity in patients with baseline CD4 counts above 250 cells/mm3 regardless of the patient’s sex [7]. Here, CD4 is linked to AIDS.